Marksans Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 18, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	94,009	100,815	68,836	31,903	18,627	20,445
Market Cap Growth	-3.97%	46.46%	115.77%	71.27%	-8.89%	259.35%
Enterprise Value	90,912	96,315	63,549	29,746	16,052	19,467
Last Close Price	207.45	221.69	151.06	69.62	44.78	48.99
PE Ratio	26.10	26.49	21.94	11.98	9.97	8.57
Forward PE	19.96	5.39	5.39	5.39	5.39	5.39
PS Ratio	3.35	3.84	3.16	1.72	1.25	1.49
PB Ratio	3.46	4.05	3.30	1.81	1.52	2.26
P/TBV Ratio	3.69	4.28	3.51	1.95	1.67	2.50
P/FCF Ratio	-	298.76	319.14	17.36	35.20	15.47
P/OCF Ratio	-	48.78	29.88	13.44	18.77	11.45
PEG Ratio	1.10	0.80	0.80	0.80	0.80	0.80
EV/Sales Ratio	3.24	3.67	2.92	1.61	1.08	1.42
EV/EBITDA Ratio	17.51	19.21	14.65	9.29	6.68	5.81
EV/EBIT Ratio	21.09	21.63	16.54	10.34	7.50	6.30
EV/FCF Ratio	-	285.42	294.63	16.19	30.33	14.73
Debt / Equity Ratio	0.12	0.13	0.12	0.07	0.09	0.04
Debt / EBITDA Ratio	0.64	0.61	0.53	0.36	0.43	0.12
Debt / FCF Ratio	-	9.54	11.32	0.67	2.09	0.30
Net Debt / Equity Ratio	-0.12	-0.15	-0.22	-0.34	-0.19	-0.19
Net Debt / EBITDA Ratio	-0.68	-0.77	-1.05	-1.85	-0.98	-0.52
Net Debt / FCF Ratio	-	-11.38	-21.20	-3.23	-4.46	-1.31
Asset Turnover	-	0.89	0.89	0.97	1.04	1.29
Inventory Turnover	-	1.64	1.95	2.07	1.76	1.87
Quick Ratio	-	2.64	2.99	3.34	2.09	1.62
Current Ratio	-	4.62	4.78	4.91	3.37	3.02
Return on Equity (ROE)	-	16.73%	16.35%	17.76%	17.55%	30.69%
Return on Assets (ROA)	-	9.40%	9.86%	9.39%	9.33%	18.13%
Return on Invested Capital (ROIC)	13.76%	18.11%	20.40%	20.94%	18.80%	36.93%
Return on Capital Employed (ROCE)	-	16.10%	16.80%	15.60%	16.70%	33.30%
Earnings Yield	3.83%	3.77%	4.56%	8.35%	10.03%	11.67%
FCF Yield	-	0.34%	0.31%	5.76%	2.84%	6.46%
Dividend Yield	0.39%	0.36%	0.40%	0.72%	0.56%	0.51%
Payout Ratio	-	7.14%	7.22%	3.82%	5.67%	1.72%
Buyback Yield / Dilution	-0.10%	-	-9.09%	-1.49%	-	0.00%
Total Shareholder Return	0.28%	0.36%	-8.69%	-0.77%	0.56%	0.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.